Fundz

A2 Biotherapeutics reported raising $60.9 Million in an initial SEC Form D filing, from an offering of $69.8 Million

PRIVATENov 17, 2022$60.9M of $69.8M raised

Amount Raised

$60.9 Million

$60.9 Million sold, per SEC Form D (first sale Nov 4, 2022)

Round Type

Venture

Agoura HillsBiotechnology

Quick answer

A2 Biotherapeutics, Inc. raised $60.9 Million in a funding round, dated November 4, 2022. A2 Biotherapeutics, Inc. is based in Agoura Hills, California, United States.

How much did A2 Biotherapeutics, Inc. raise?
A2 Biotherapeutics, Inc. raised $60.9 Million in a funding round on November 4, 2022.
What does A2 Biotherapeutics, Inc. do?
A2 is dedicated to pushing the boundaries of science to transform medicine and turn the tide on cancer.
Where is A2 Biotherapeutics, Inc. based and how big is it?
A2 Biotherapeutics, Inc. is based in Agoura Hills, California, United States. Fundz records about 138 employees.
Who are the decision-makers at A2 Biotherapeutics, Inc?
Fundz holds 2 contacts at A2 Biotherapeutics, Inc., including the CEO. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as A2 Biotherapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • CARMAT raised an undisclosed amount (Funding Round) on December 19, 2022.
  • NeuroX Innovations raised $325K (Seed) on December 19, 2022.
  • EnginZyme raised $22M (Series B) on December 19, 2022.
  • Protillion Biosciences raised $18M (Series A) on December 19, 2022.
  • Vistim Labs raised $300K (Seed) on December 19, 2022.
  • Vitazi.AI raised $1.2M (Seed) on December 16, 2022.

Who to call at A2 Biotherapeutics, Inc., and when

A new round usually means A2 Biotherapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day A2 Biotherapeutics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at A2 Biotherapeutics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at A2 Biotherapeutics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

A2 Biotherapeutics, Inc.

Location

30301 AGOURA ROAD, #210

Agoura Hills, California, United States

About

A2 is dedicated to pushing the boundaries of science to transform medicine and turn the tide on cancer. We are focused on the next frontier in cell therapy: solid tumors. A2 engineers T cells that target the loss of genetic material in tumors, enabling the selective killing of tumor cells while leaving normal cells unharmed. The company was founded in 2018 by Alexander Kamb, Michael Gallo and Paul Kang and has raised $136M since inception. Our investors include The Column Group, Vida Ventures, Samsara BioCapital, Nextech Invest, Casdin Capital, Euclidean Capital, UC Investments (Office of the Chief Investment Officer of the Regents) and Hartford HealthCare Endowment.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment A2 Biotherapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsScott F., CEO hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for A2 Biotherapeutics, Inc.'s next move

See what Strategic adds

A2 Biotherapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.